Annovis Bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Annovis Bio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 14.28K shares, a 95.24% decline from fiscal 2024.
- Annovis Bio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 300.00K shares, a 400.86% increase from fiscal 2023.
- Annovis Bio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 59.90K shares, a 14.56% decline from fiscal 2022.
- Annovis Bio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 70.10K shares, a 56.14% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 14.28K shares 10-K · filed 2026-03-13 | |
| 2024-12-31 | 300.00K shares 10-K · filed 2025-03-21 | |
| 2023-12-31 | 59.90K shares 10-K · filed 2024-03-29 | |
| 2022-12-31 | 70.10K shares 10-K · filed 2024-03-29 | |
| 2021-12-31 | 159.81K shares 10-K · filed 2023-03-31 | |
| 2020-12-31 | 48.44K shares 10-K · filed 2022-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |